BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 11377487)

  • 1. The value of routine monitoring of mycophenolic acid plasma levels after clinical heart transplantation.
    Hesse CJ; Vantrimpont P; van Riemsdijk-van Overbeeke IC; van Gelder T; Balk AH; Weimar W
    Transplant Proc; 2001 May; 33(3):2163-4. PubMed ID: 11377487
    [No Abstract]   [Full Text] [Related]  

  • 2. Primary immunosuppression with tacrolimus and mycophenolate mofetil versus cyclosporine and azathioprine in heart transplant recipients.
    Teebken OE; Strüber M; Harringer W; Pichlmaier MA; Haverich A
    Transplant Proc; 2002 Jun; 34(4):1265-8. PubMed ID: 12072335
    [No Abstract]   [Full Text] [Related]  

  • 3. Overestimation of mycophenolic acid by EMIT correlates with MPA metabolite.
    Shipkova M; Schütz E; Armstrong VW; Niedmann PD; Wieland E; Oellerich M
    Transplant Proc; 1999; 31(1-2):1135-7. PubMed ID: 10083508
    [No Abstract]   [Full Text] [Related]  

  • 4. Therapeutic drug monitoring of mycophenolic acid: comparison of HPLC and immunoassay reveals new MPA metabolites.
    Schütz E; Shipkova M; Armstrong VW; Niedmann PD; Weber L; Tönshoff B; Pethig K; Wahlers T; Braun F; Ringe B; Oellerich M
    Transplant Proc; 1998 Jun; 30(4):1185-7. PubMed ID: 9636479
    [No Abstract]   [Full Text] [Related]  

  • 5. The efficacy of the combination of tacrolimus and mycophenolate mofetil for prevention of acute myocardial rejection is dependent on routine monitoring of mycophenolic acid trough acid levels.
    Meiser BM; Pfeiffer M; Schmidt D; Ueberfuhr P; Reichenspurner H; Paulus D; von Scheidt W; Kreuzer E; Seidel D; Reichart B
    Transplant Proc; 1999; 31(1-2):84-7. PubMed ID: 10083018
    [No Abstract]   [Full Text] [Related]  

  • 6. Histopathological findings in heart transplant patients under tacrolimus-mycophenolate mofetil versus cyclosporine microemulsion-azathioprine.
    Sgrosso JL; Ferrer J; Araujo G; Romeo L; Parisi C; Vázquez MC
    Transplant Proc; 2002 Feb; 34(1):115-6. PubMed ID: 11959214
    [No Abstract]   [Full Text] [Related]  

  • 7. Ten-year results of a randomized trial comparing tacrolimus versus cyclosporine a in combination with mycophenolate mofetil after heart transplantation.
    Guethoff S; Meiser BM; Groetzner J; Eifert S; Grinninger C; Ueberfuhr P; Reichart B; Hagl C; Kaczmarek I
    Transplantation; 2013 Feb; 95(4):629-34. PubMed ID: 23423270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycophenolic acid concentrations in long-term heart transplant patients: relationship with calcineurin antagonists and acute rejection.
    Cantin B; Giannetti N; Parekh H; Panchal SN; Kwok BW; Najem R; Woodman K; Hunt SA; Valantine HA
    Clin Transplant; 2002 Jun; 16(3):196-201. PubMed ID: 12010143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical experience with Prograf (tacrolimus, FK 506) in Chinese patients after renal transplantation.
    Yu L; Wang Y; Fu SJ; Cheng XJ
    Transplant Proc; 2000 Nov; 32(7):1709-10. PubMed ID: 11119902
    [No Abstract]   [Full Text] [Related]  

  • 10. The efficacy of mycophenolate mofetil treatment in the prevention of acute renal rejection is related to plasma level of mycophenolic acid.
    Kuriata-Kordek M; Boratyńska M; Klinger M; Woźniak M; Urbaniak J; Szyber P; Patrzalek D; Tupka D
    Transplant Proc; 2002 Nov; 34(7):2985-7. PubMed ID: 12431678
    [No Abstract]   [Full Text] [Related]  

  • 11. A randomized long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil versus cyclosporine (NEORAL) and sirolimus in renal transplantation. I. Drug interactions and rejection at one year.
    Ciancio G; Burke GW; Gaynor JJ; Mattiazzi A; Roth D; Kupin W; Nicolas M; Ruiz P; Rosen A; Miller J
    Transplantation; 2004 Jan; 77(2):244-51. PubMed ID: 14742989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of mycophenolate mofetil in heart transplant recipients.
    Seebacher G; Mallinger R; Laufer G; Grimm M; Griesmacher A; Weigel G; Wolner E; Müller MM
    Adv Exp Med Biol; 1998; 431():801-3. PubMed ID: 9598174
    [No Abstract]   [Full Text] [Related]  

  • 13. Suggested guidelines for the use of tacrolimus in cardiac transplant recipients.
    Taylor DO; Barr ML; Meiser BM; Pham SM; Mentzer RM; Gass AL
    J Heart Lung Transplant; 2001 Jul; 20(7):734-8. PubMed ID: 11448799
    [No Abstract]   [Full Text] [Related]  

  • 14. High variability of drug exposure: a biopharmaceutic risk factor for chronic rejection.
    Kahan BD
    Transplant Proc; 1998 Aug; 30(5):1639-41. PubMed ID: 9723224
    [No Abstract]   [Full Text] [Related]  

  • 15. The impact of routine mycophenolate mofetil drug monitoring on the treatment of cardiac allograft rejection.
    Yamani MH; Starling RC; Goormastic M; Van Lente F; Smedira N; McCarthy P; Young JB
    Transplantation; 2000 Jun; 69(11):2326-30. PubMed ID: 10868634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved survival after lung transplantation in patients treated with tacrolimus/mycophenolate mofetil as compared with cyclosporine/azathioprine.
    Izbicki G; Shitrit D; Aravot D; Sulkes J; Saute M; Sahar G; Kramer MR
    Transplant Proc; 2002 Dec; 34(8):3258-9. PubMed ID: 12493439
    [No Abstract]   [Full Text] [Related]  

  • 17. Tacrolimus/mycophenolate provides superior immunosuppression relative to neoral/mycophenolate in synchronous pancreas-kidney transplantation.
    Bruce DS; Woodle ES; Newell KA; Millis JM; Cronin DC; Loss GE; Grewal HP; Siegel CT; Pellar S; Josephson MA; Thistlethwaite JR
    Transplant Proc; 1998 Jun; 30(4):1538-40. PubMed ID: 9636625
    [No Abstract]   [Full Text] [Related]  

  • 18. Scientific principles for mycophenolic acid therapeutic drug monitoring.
    Shaw LM; Korecka M; Aradhye S; Grossman R; Barker C; Naji A; Brayman KL
    Transplant Proc; 1998 Aug; 30(5):2234-6. PubMed ID: 9723454
    [No Abstract]   [Full Text] [Related]  

  • 19. Relation of mycophenolic acid trough levels and adverse events in kidney allograft recipients.
    Smak Gregoor PJ; Hesse CJ; van Gelder T; van der Mast BJ; IJzermans JN; van Besouw NM; Weimar W
    Transplant Proc; 1998 Jun; 30(4):1192-3. PubMed ID: 9636482
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term results of mycophenolate mofetil as part of immunosuppressive induction therapy after liver transplantation.
    Langrehr JM; Klupp J; Glanemann M; Junge G; Pfitzmann R; Bahra M; Radtke C; Neumann U; Neuhaus R; Neuhaus P
    Clin Transplant; 2006; 20(3):272-83. PubMed ID: 16824141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.